Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Oxaliplatin
Sponsor: Hoosier Cancer Research Network
Collaborators: Sanofi|Hoffmann-La Roche|Walther Cancer Institute